Patricia Silva, PhD

Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Patricia Silva, PhD

March 15, 2017 Columns by Patricia Silva, PhD

Patricia Silva, PhD

Articles by Patricia Silva, PhD

Walk In, Roll Out: The Conundrum of Cardio Exercise with MS

Pilot Study May Lead to Telemedicine Benefiting People with Multiple Sclerosis

Fungal Compound Boosts Axon Regeneration, Offering Clue for MS Treatment

Muscle Health Test Shows Importance of Exercise in Multiple Sclerosis

UMass Amherst Receives $833,000 Pentagon Grant to Create Improved MS Diagnostic Test

IQuity to Release 7-Day Blood Diagnostics Test for Multiple Sclerosis in May

Australians Living with MS Lack Adequate Oral Care, Study Finds

Walk MS 2017 Events Expected to Bring Total Fundraising for Multiple Sclerosis Past $1 Billion

National MS Society Forms Coalition With 10 Other Groups on Obamacare Reform

Horseback Riding Helps People with Movement Disabilities, Review of 16 Studies Concludes

Older SPMS Patients More Likely to Suffer from Fatigue, Limited Leg Function, Study Says

Altered Immune Response in MS Is What May Allow Infections to Kill, Mouse Study Suggests

Innate to Complete Phase 2b Trial for MIS416 Therapy in Secondary Progressive MS Patients

MS Organizations Join #MySupportHero Initiative to Help Patients Salute Those Who Care

MSAA Releases Promotional Video to Mark Multiple Sclerosis Awareness Month

Acthar Gel of Dubious Value in Treating MS Despite its $34,000-Per-Vial Cost, Study Finds

‘Ocrevus Has the Potential to Change How MS Is Treated,’ Genentech’s Peter Chin Says in Interview

Full Transcript of Interview with Genentech’s Medical Director, Peter Chin, on Ocrevus

#ACTRIMS2017 – Novantrone Lowers Relapse Rates over Long Term, But Carries Cancer Risk

#ACTRIMS2017 – Epigenetics’ Role in Myelin Renewal Is Focus of Research

#ACTRIMS2017 – Sex Hormones and Chromosomes Lead to Gender Differences in MS, Studies Report

#ACTRIMS2017 – 3 Trials Show MS Patients Receiving Ocrevus Had No Elevated Infection Risk

#ACTRIMS2017 – Some Fatty Acids in Diet Help, Others Hurt Immune System, Study Reports

#ACTRIMS2017 – Sun Exposure May Lower Fatigue, Slow Disability Progression in MS

#ACTRIMS2017 – No Evidence of Progression More Likely Among PPMS Patients on Ocrevus

#ACTRIMS2017 – Airway Infections May Be More Common in MS Due to Altered Immune Response in Lungs

Brazil Allows HempMeds to Import RSHO Cannabidiol for MS Treatment

Apitope’s ATX-MS-1468 Therapy Decreases Brain Lesions in Relapsing MS Patients

Exploring Methods to Manage MS-Related Fatigue

#ACTRIMS2017 – Phase 2 Trial Data Shows Better Walking Speeds in MS Patients Using ADS-5102

Subscribe to our newsletter